Teleflex Incorporated (TFX): Price and Financial Metrics
Teleflex Incorporated (TFX)
Today's Latest Price: $375.23 USD
Updated Jan 27 2:58pm
Add TFX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 188 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
TFX Stock Summary
- With a one year PEG ratio of 826.83, Teleflex Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.19% of US stocks.
- Teleflex Inc's stock had its IPO on February 18, 1988, making it an older stock than 89.29% of US equities in our set.
- In terms of volatility of its share price, TFX is more volatile than merely 4.73% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Teleflex Inc, a group of peers worth examining would be GNRC, XYL, FTV, PKI, and STE.
- TFX's SEC filings can be seen here. And to visit Teleflex Inc's official web site, go to www.teleflex.com.
TFX Stock Price Chart Interactive Chart >
TFX Price/Volume Stats
| Current price | $375.23 | 52-week high | $414.72 |
| Prev. close | $382.80 | 52-week low | $221.27 |
| Day low | $371.83 | Volume | 105,060 |
| Day high | $379.41 | Avg. volume | 222,484 |
| 50-day MA | $389.18 | Dividend yield | 0.36% |
| 200-day MA | $366.55 | Market Cap | 17.47B |
Teleflex Incorporated (TFX) Company Bio
Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company was founded in 1943 and is based in Wayne, Pennsylvania.
TFX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $375.23 | $64.71 | -83% |
We started the process of determining a valid price forecast for Teleflex Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Teleflex Inc ranked in the 17th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Teleflex Inc, consider:
- The company has produced more trailing twelve month cash flow than 61.74% of its sector Healthcare.
- 89% of the company's capital comes from equity, which is greater than 70.81% of stocks in our cash flow based forecasting set.
- TFX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 32.07% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -83% |
| 1% | -83% |
| 2% | -83% |
| 3% | -83% |
| 4% | -83% |
| 5% | -83% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as TFX, try AMPH, LGND, CNMD, LMNX, and ZBH.
Loading social stream, please wait...